摘要
甲胎蛋白阳性的非肝脏消化系统肿瘤是一组具有相似病理特征的疾病,较普通消化道肿瘤更易发生淋巴道和远处转移,恶性程度及侵袭性更高。国内外多项研究发现,甲胎蛋白在疾病筛查、疗效评价和预后判断中发挥重要作用,但关于这类肿瘤的发病机制、诊断标准及治疗等方面的研究有限。在这篇综述中,我们讨论了甲胎蛋白在非肝脏消化系统肿瘤中的研究进展,为临床诊断及治疗提供参考。
Alpha-fetoprotein-positive carcinoma from non-hepatic digestive system is a group of diseases with similar pathological characteristics, compared with common digestive tract tumor, which is more prone to lymphatic and distant metastasis, higher degree of malignancy and aggressiveness. A num-ber of studies at home and abroad have found that, alpha-fetoprotein plays an important role in disease screening, efficacy evaluation and prognosis judgment. However, the pathogenesis, diag-nostic criteria and treatment research of this tumor is limited. This review discusses the progress of alpha-fetoprotein-positive in non-hepatic digestive system tumors to provide a reference for clinical diagnosis and treatment.
出处
《临床医学进展》
2022年第11期10753-10758,共6页
Advances in Clinical Medicine
